Form 4: Hologic CEO Stephen Macmillan Transfers Shares to Family Trust

Hologic's CEO, Stephen Macmillan, reports transferring 24,000 shares of common stock to the MacMillan Family Trust in April 2024.

Summary

• Stephen Macmillan, the Chairman, President, and CEO of Hologic Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On April 19 and April 22, 2024, Macmillan transferred a total of 24,000 shares of Hologic common stock to the MacMillan Family Trust.
• Following these transactions, Macmillan directly owns 1,227,088 shares and indirectly owns 1,088,954 shares through the MacMillan Family Trust.
• The directly owned shares include 1,079,673 restricted stock units/performance stock units with deferred settlement under Hologic's Deferred Equity Plan.
• Macmillan is a trustee and beneficiary of the MacMillan Family Trust, making him an indirect beneficial owner of the shares held by the trust.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates a transfer of shares to a family trust, which is a common estate planning strategy.

Related Party Transactions

• The transfer of shares to the MacMillan Family Trust is a related party transaction.

Stakeholder Impact

• The transfer of shares to a family trust is unlikely to have a significant impact on stakeholders.

Key Dates